Lorence H. Kim

This profile gathers the share dealings of Lorence H. Kim across 3 companies, led by Revolution Medicines, Inc., Cencora, Inc. and Cowen Inc. The record holds 21 filings, for trades running from 25 February 2022 to 8 September 2026.

In open-market terms, that means 2 purchases worth €1.8M on one side and 7 sales worth €3.1M on the other. Taken together, the sales exceed the purchases by €1.3M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 11 share grants. In 2026 alone, the filings show no purchases and 7 sales.

The record was last updated on 10 September 2026 with an open-market sale (€125k) in Revolution Medicines, Inc. The last insider purchase was made public on 25 July 2022, 1,546 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.